International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
2015 · Neurology · 4,341 citations
https://doi.org/10.1212/wnl.0000000000001729
B
Benjamin Greenberg
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
415
Papers
17.4K
Citations
59
h-index
168
i10-index
Benjamin Greenberg is an academic researcher from The University of Texas Southwestern Medical Center. The author has contributed to research in topics: Multiple Sclerosis Research Studies & Peripheral Neuropathies and Disorders & Immunotherapy and Immune Responses. The author has an h-index of 59, co-authored 353 publications.
ORCID: 0000-0002-2091-8201Papers by this author
worksTrial of Satralizumab in Neuromyelitis Optica Spectrum Disorder
2019 · New England Journal of Medicine · 605 citations
https://doi.org/10.1056/nejmoa1901747
Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial
2020 · The Lancet Neurology · 456 citations
https://doi.org/10.1016/s1474-4422(20)30078-8
Acute flaccid myelitis: cause, diagnosis, and management
2020 · The Lancet · 171 citations
https://doi.org/10.1016/s0140-6736(20)32723-9
Home-Based Pediatric Teleneuropsychology: A validation study
2020 · Archives of Clinical Neuropsychology · 71 citations
https://doi.org/10.1093/arclin/acaa070
Immune Responses and Immunosuppressive Strategies for Adeno-Associated Virus-Based Gene Therapy for Treatment of Central Nervous System Disorders: Current Knowledge and Approaches
2022 · Human Gene Therapy · 60 citations
https://doi.org/10.1089/hum.2022.138
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat